Development and characterization of skin permeation retardants and enhancers: A comparative study of levothyroxine-loaded PNIPAM, PLA, PLGA and EC microparticles

Biopharmaceutics and Drug Disposition

Volumn 32, Issue 7, 2011, Pages 380-388

  Azarbayjani, Anahita Fathi ^a,b   Khu, Jia Vu ^a   Chan, Yew Weng ^c   Chan, Sui Yung ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

ethyl cellulose; penetration enhancers; penetration retardants; poly (N isopropylacrylamide); poly d, l lactide

Indexed keywords

ETHYL CELLULOSE; LEVOTHYROXINE; POLY(N ISOPROPYLACRYLAMIDE); POLYGLACTIN; POLYLACTIDE;

ARTICLE; CONFOCAL LASER MICROSCOPY; DRUG ACCUMULATION; DRUG PENETRATION; DRUG STABILITY; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; HUMAN; HUMAN TISSUE; MICROENCAPSULATION; TEMPERATURE DEPENDENCE;

ACRYLIC RESINS; CELLULOSE; DRUG CARRIERS; DRUG STABILITY; DRUG STORAGE; HUMANS; LACTIC ACID; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; PERMEABILITY; POLYGLYCOLIC ACID; POLYMERS; SKIN; THYROXINE;

EID: 80053196368     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.766     Document Type: Article

References (39)

1. Kang H, Liu W, He B, Shen D, Ma L, Huang Y,. Synthesis of amphiphilic ethyl cellulose grafting poly (acrylic acid) copolymers and their self-assembly morphologies in water. Polymer 2006; 47: 7927-7934. (Pubitemid 44740023)
2. Duarte ARC, Gordillo MD, Cardoso MM, Simplício AL, Duarte CMM,. Preparation of ethyl cellulose/methyl cellulose blends by supercritical antisolvent precipitation. Int J Pharm 2006; 311: 50-54.
3. Crowley MM, Schroeder B, Fredersdorf A, et al,. Physicochemical properties and mechanism of drug release from ethyl cellulose matrix tablets prepared by direct compression and hot-melt extrusion. Int J Pharm 2004; 269: 509-522. (Pubitemid 38045312)
4. Basarkar A, Devineni D, Palaniappan R, Singh J,. Preparation, characterization, cytotoxicity and transfection efficiency of poly (dl -lactide-co-glycolide) and poly (dl -lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA. Int J Pharm 2007; 343: 247-254. (Pubitemid 47334869)
5. Guo X, Zhang L, Qian Y, Zhou J,. Effect of composition on the formation of poly (dl -lactide) microspheres for drug delivery systems: Mesoscale simulations. J Chem Eng 2007; 131: 195-201. (Pubitemid 46734755)
6. Singh S, Webster DC, Singh J,. Thermosensitive polymers: synthesis, characterization, and delivery of proteins. Int J Pharm 2007; 341: 68-77. (Pubitemid 47088108)
7. Schmaljohann D,. Thermo- and pH-responsive polymers in drug delivery. Adv Drug Deliv Rev 2006; 58: 1655-1670. (Pubitemid 44830149)
8. Dimitrov I, Trzebicka B, Müller AHE, Dworak A, Tsvetanov CB,. Thermosensitive water-soluble copolymers with doubly responsive reversibly interacting entities. Prog Polym Sci 2007; 32: 1275-1343. (Pubitemid 47513189)
9. Makino K, Hiyoshi J, Ohshima H,. Effects of thermosensitivity of poly (N-isopropylacrylamide) hydrogel upon the duration of a lag phase at the beginning of drug release from the hydrogel. Colloids Surf B Biointerfaces 2001; 20: 341-346. (Pubitemid 32106901)
10. Patel H, Stalcup A, Dansereau R, Sakr A,. The effect of excipients on the stability of levothyroxine sodium pentahydrate tablets. Int J Pharm 2003; 264: 35-43. (Pubitemid 37297632)
11. Volpato NM, Silva RL, Brito APP, GonÃalves JCS, Vaisman M, NoÃl F,. Multiple level C in vitro/in vivo correlation of dissolution profiles of two l -thyroxine tablets with pharmacokinetics data obtained from patients treated for hypothyroidism. Eur J Pharm Sci 2004; 21: 655-660. (Pubitemid 38447147)
12. Arduino C, Eandi M,. Kinetics of thyroxine epicutaneous absorption. Pharmacol Res 1989; 21: 109-110. (Pubitemid 19107187)
13. Santini F, Vitti P, Chiovato L, et al,. Role for inner ring deiodination preventing transcutaneous passage of thyroxine. J Clin Endocrinol Metab 2003; 88: 2825-2830. (Pubitemid 36724463)
14. Leo E, Pecquet S, Rojas J, Couvruer P, Fattal E,. Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by w/o/w solvent evaporation method. J Microencaps 1998; 15: 421-430. (Pubitemid 28288731)
15. Rapaka RS, Roth J, Brine GA, Prasad VK,. A simple HPLC method for the dissolution studies on levothyroxine sodium tablets. Int J Pharm 1982; 12: 285-294. (Pubitemid 13235966)
16. Kligman AM, Christophers E,. Preparation of isolated sheets of human stratum corneum. Arch Dermatol 1963; 88: 702-705.
17. Wischke C, Lorenzen D, Zimmermann J, Borchert H-H,. Preparation of protein loaded poly(d,l -lactide-co-glycolide) microparticles for the antigen delivery to dendritic cells using a static micromixer. Eur J Pharm Biopharm 2006; 62: 247-253. (Pubitemid 43356572)
18. Crotts G, Park TG,. Preparation of porous and nonporous biodegradable polymeric hollow microspheres. J Control Release 1995; 35: 91-105.
19. Niwa T, Takeuchi H, Hino T, Kunou N, Kawashima Y,. Effects of selected formulation parameters on the entrapment of diclofenac sodium in ethyl cellulose microspheres. J Control Release 1993; 25: 89-98.
20. Lopez VC, Hadgraft J, Snowden MJ,. The use of colloidal microgels as a (trans) dermal drug delivery system. Int J Pharm 2005; 292: 137-147. (Pubitemid 40255795)
21. de Jalõn EG, Blanco-Príeto MJ, Ygartua P, Santoyo S,. Topical application of acyclovir-loaded microparticles: Quantification of the drug in porcine skin layers. J Control Release 2001; 75: 191-197. (Pubitemid 32635209)
22. Mayorga P, Deharo E, Puisieux F, Couarraze G,. Interpretation and prediction of plasma levels of primaquine following transdermal delivery in Swiss mice. Int J Pharm 1997; 155: 99-107. (Pubitemid 27368127)
23. Rama Rao P, Reddya MN, Ramakrishna S, Diwan PV,. Comparative in vivo evaluation of propranolol hydrochloride after oral and transdermal administration in rabbits. Eur J Pharm Biopharm 2003; 56: 81-85. (Pubitemid 36802050)
24. Amnuaikit C, Ikeuchi I, Ogawara K-I, Higaki K, Kimura T,. Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use. Int J Pharm 2005; 289: 167-178. (Pubitemid 40093551)
25. Kangarlou S, Haririan I, Gholipour Y,. Physico-mechanical analysis of free ethyl cellulose films comprised with novel plasticizers of vitamin resources. Int J Pharm 2008; 356: 153-166.
26. Middleton JC, Tipton AJ,. Synthetic biodegradable polymers as orthopedic devices. Biomaterials 2000; 21: 2335-2346.
27. Packhaeuser CB, Kissel T,. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly (vinyl alcohol)-g-poly (lactide-co-glycolide) nanoparticles. J Control Release 2007; 123: 131-140. (Pubitemid 47562140)
28. Henry F, Costa LC, Devassine M,. The evolution of poly (lactic acid) degradability by dielectric spectroscopy measurements. Eur Polym J 2005; 41: 2122-2126. (Pubitemid 40970685)
29. Tarvainen M, Sutinen R, Peltonen S, et al,. Enhanced film-forming properties for ethyl cellulose and starch acetate using n-alkenyl succinic anhydrides as novel plasticizers. Eur J Pharm Sci 2003; 19: 363-371. (Pubitemid 36952398)
30. Frohoff-Hülsmann MA, Lippold BC, McGinity JW,. Aqueous ethyl cellulose dispersion containing plasticizers of different water solubility and hydroxypropyl methyl-cellulose as coating material for diffusion pellets II: properties of sprayed films. Eur J Pharm Biopharm 1999; 48: 67-75. (Pubitemid 29308928)
31. Rowe RC, Kotaras AD, White EFT,. An evaluation of the plasticizing efficiency of the dialkyl phthalates in ethyl cellulose films using the torsional braid pendulum. Int J Pharm 1984; 22: 57-62. (Pubitemid 15209705)
32. Choi C, Chae SY, Nah J-W,. Thermosensitive poly(N-isopropylacrylamide)-b- poly (Îμ-caprolactone) nanoparticles for efficient drug delivery system. Polymer 2006; 47: 4571-4580. (Pubitemid 43870230)
33. Geever LM, Devine DM, Nugent MJD, et al,. Lower critical solution temperature control and swelling behaviour of physically crosslinked thermosensitive copolymers based on N-isopropylacrylamide. Eur Polym J 2006; 42: 2540-2548. (Pubitemid 44436155)
34. Luengo J, Weiss B, Schneider M, et al,. Influence of nanoencapsulation on human skin transport of flufenamic acid. Skin Pharmacol Physiol 2006; 19: 190-197. (Pubitemid 44114517)
35. Hadgraft J, Peck J, Williams DG, Pugh WJ, Allan G,. Mechanism of action of skin penetration enhancers/retarders: Azone and analogues. Int J Pharm 1996; 141: 17-25. (Pubitemid 26302908)
36. Asbill CS, Michniak BB,. Percutaneous penetration enhancers: Local versus transdermal activity. Pharm Sci Technol Today 2000; 3: 36-41. (Pubitemid 30066493)
37. Bernard G, Auger M, Soucy J, Pouliot R,. Physical characterization of the stratum corneum of an in vitro psoriatic skin model by ATR-FTIR and Raman spectroscopies. Biochim Biophys Acta 2007; 1770: 1317-1323. (Pubitemid 47248058)
38. Goates CY, Knutson K,. Enhanced permeation and stratum corneum structural alterations in the presence of dithiothreitol. Biochim Biophys Acta 1993; 1153: 289-298. (Pubitemid 24028301)
39. Goates CY, Knutson K,. Enhanced permeation of polar compounds through human epidermis. I. Permeability and membrane structural changes in the presence of short chain alcohols. Biochim Biophys Acta 1994; 1195: 169-179. (Pubitemid 24318107)